Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review
{{output}}
Triple-negative breast cancer (TNBC) is characterized by less treatment responsiveness and poorer prognosis than other breast cancer subtypes. The introduction of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunotherapy has expa... ...
